{"certainAgreement":{"otherDetails":"Agreements varied with individual investigators, but did not prohibit any investigator from publishing. Investigators were not to publish results of the study until a period of time (eg. 2 years) following completion of the trial at all participating institutions but could do so earlier with consent of the Sponsor.","piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true},"pointOfContact":{"email":"GSKClinicalSupportHD@gsk.com","organization":"Sierra Oncology, a GlaxoSmithKline company","phone":"866-435-7343","title":"GSK Response Center"}}